Navigation Links
VIVUS Provides Qnexa Regulatory Update
Date:1/9/2012

ical trial data; our response to questions and requests for additional information including additional pre-clinical or clinical studies from the European Medicines Agency, or EMA, and the Committee for Medicinal Products for Human Use, or CHMP, of the Marketing Authorization Application, or MAA, for Qnexa; the results of external studies to assess the teratogenic risk of topiramate; results of the REMS or cardiovascular outcomes for obesity advisory meetings; the outcome of the second advisory committee meeting for Qnexa; the impact, if any, of the agreement by one of our competitors with an obesity compound to conduct or complete a cardiovascular outcomes study pre-approval; impact on future sales based on specific indication and contraindications contained in the label and extent of the REMS, distribution and patient access program; the FDA's response to the NDA filed for avanafil; our ability to successfully commercialize or establish a marketing partnership for avanafil or our partner's ability to obtain regulatory approval to manufacture and adequately supply avanafil for commercial use; our history of losses and variable quarterly results; substantial competition; risks related to the failure to protect our intellectual property and litigation in which we may become involved; uncertainties of government or third party payer reimbursement; our reliance on sole source suppliers; our limited sales and marketing efforts and our reliance on third parties; failure to continue to develop innovative investigational drug candidates and drugs; risks related to the failure to obtain FDA or foreign authority clearances or approvals and noncompliance with FDA regulations; our ability to demonstrate through clinical testing the safety and effectiveness of our investigational drug candidates; our dependence on the performance of our collaborative partners; the timing of initiation and completion of clinical trials and submissions to the FDA or foreign authorities; the volat
'/>"/>
SOURCE VIVUS, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. VIVUS Announces Date of FDA Advisory Committee Review of Qnexa for the Treatment of Obesity
2. VIVUS Reports Topline Findings From FORTRESS
3. VIVUS to Present at the Credit Suisse 2011 Healthcare Conference
4. VIVUS Resubmits Qnexa NDA to the FDA
5. VIVUS Provides Regulatory Update on QNEXA
6. VIVUS Announces FDA Acceptance of Avanafil New Drug Application for Treatment of Erectile Dysfunction
7. VIVUS Announces $45.8 Million Registered Direct Offering of Common Stock
8. VIVUS Reports Second Quarter and First Six Months 2011 Financial Results
9. VIVUS Reports 2010 Fourth Quarter and Full-Year Financial Results
10. VIVUS to Present at Three Upcoming Investor Conferences in March
11. VIVUS Provides Regulatory Update on QNEXA NDA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... , July 28, 2014  Isis Pharmaceuticals, Inc. ... Pharmaceuticals, Second Quarter 2014 Financial Results and Highlights Conference ... a.m. PTWhere: www.isispharm.com How:Live on the Internet. Simply ... unable to participate during the live event, a replay ... time at www.isispharm.com . ABOUT ISIS ...
(Date:7/28/2014)... 28, 2014 OmPrompt today ... to help it meet the global demand for ... and logistics. Albion joins Shackleton Ventures. ... Over the past 18 months OmPrompt has underpinned ... management team and its operations. The new funding ...
(Date:7/25/2014)... , July 25, 2014  Depomed, Inc. (NASDAQ: ... second quarter fiscal year 2014 financial results after the ... host a conference call beginning at 4:30 pm EDT, 1:30 ... access the call by dialing 877-317-6789 ( United ... will also be available via a live webcast on ...
Breaking Medicine Technology:Webcast Alert: Isis Pharmaceuticals' Second Quarter 2014 Financial Results Conference Call 2OmPrompt Funded for Customer Automation Management Market Expansion 2Depomed To Report Second Quarter Fiscal Year 2014 Financial Results On Wednesday, August 6, 2014 2
... May 7, 2012  Zenobia Therapeutics, Inc. (Zenobia), the ... diseases and FBLD/structural biology services, and BioBlocks, Inc. ... novel building block products, announced today that they ... their product offerings.  The library, ZB-Fragment Library 2, ...
... 7, 2012  BioElectronics Corporation (OTC-PINK: BIEL), the maker ... devices, today announced the completion of a randomized, ... BIEL,s ActiPatch® product.  ActiPatch uses pulsed electromagnetic field ... healing of injured tissue. A ...
Cached Medicine Technology:Zenobia Therapeutics, Inc. And BioBlocks, Inc. Announce Sale Of A Joint Fragment Library Ideal For Screening By All Popular Methods 2Zenobia Therapeutics, Inc. And BioBlocks, Inc. Announce Sale Of A Joint Fragment Library Ideal For Screening By All Popular Methods 3BioElectronics' ActiPatch Reduces Muscle Soreness in Runners 2
(Date:7/28/2014)... July 28, 2014 According to court documents, ... owner of The Marcal Group (TMG), met with ... (HMG). A contract, as well a broad project outline, were ... as well as branding services and marketing. , ... by HMG throughout the course of the project, praise was ...
(Date:7/28/2014)... TherapySites, the leading website ... today its affiliation with the Illinois Association for ... allows TherapySites to continue to extend their online marketing ... offers. , “There has been a fundamental shift in ... nearly 3 billion Internet users, it is so important ...
(Date:7/28/2014)... According to the Heartburn No More PDF review recently ... help people get rid of acid reflux naturally. ... heartburn and acid reflux. In addition, inside this book, people ... factors for reflux disease. , Vkool informs in its ... symptoms of reflux disease naturally without medications. The book also ...
(Date:7/28/2014)... 28, 2014 Shore Points Capital announced ... investment in Loftware, Inc., through a recapitalization of the ... was the lead investor in Loftware for over nine ... the leading international provider of enterprise level software solutions ... a great investment for us, and we are proud ...
(Date:7/27/2014)... Petersburg, FL (PRWEB) July 28, 2014 ... water, and that is the key to the power ... our skin," says Kathy Heshelow, founder of Sublime Beauty®. ... topical Hyaluronic serum such as ours improves skin ... in the skin, key to a healthy and beautiful ...
Breaking Medicine News(10 mins):Health News:Calko Medical Center Loses Website Twice over Non-Payment, According to Court Documents 2Health News:TherapySites (Websites for Therapists) Partners with the Illinois Association for Marriage and Family Therapy 2Health News:Heartburn No More Pdf Review Exposes Jeff Martin's Guide For Treating Heartburn – Vkool.com 2Health News:Heartburn No More Pdf Review Exposes Jeff Martin's Guide For Treating Heartburn – Vkool.com 3Health News:Shore Points Capital Announces Sale of Portfolio Company Loftware 2Health News:Aging or Dry Skin Benefits from Hyaluronic Serum; Now 30% Off Sale at Sublime Beauty® 2
... for some women, study suggests , , , TUESDAY, May ... women, mammography is far from perfect. But, undergoing breast ... cancers in high-risk women, particularly those with dense breast ... authors noted, ultrasound also significantly increases the rate of ...
... slow to a crawl unless regulators work out a host ... opinion piece. , We cant apply a clinical paradigm to ... Nancy Kass, Sc.D., deputy director for public health at the ... the article. , The piece, published in the June issue ...
... May 13 CJPS Enterprises, LLC, (http://www.CJPS-Enterprises.com ) ... mini-seminar and interactive discussions about building up, or,divesting ... and therefore their worth. This seminar will take ... and is applicable to both large,and small companies., ...
... ,Yacht Party, for ... Supporting ,Yacht Tax, Loophole, LOS ANGELES, May 13 The ... the California,Republican Party as the "Yacht Party" for its continued support ... to avoid paying,sales tax in California. The ad, titled "Yacht Party ...
... Attorneys for a married,couple who lived in the fundamentalist ... District Court judge today for an emergency order,to prevent ... is still,nursing, when he turns a year old on ... presiding judge at 3:30 p.m.,seeking an emergency injunction to ...
... DALLAS, May 13 It was a sellout ... using natural botanicals,in its first hour-long show on ... Sandra Bennett and Actifirm president Elysiann Bishop,presented six ... Renovation Eye Cream; Actilash(TM); and a special,four-piece discovery ...
Cached Medicine News:Health News:Coupled With Mammography, Ultrasound Finds More Breast Cancers 2Health News:Coupled With Mammography, Ultrasound Finds More Breast Cancers 3Health News:Treating safety research like other clinical studies slows progress 2Health News:Treating safety research like other clinical studies slows progress 3Health News:Intellectual Property Buildup Seminar to be Held in Detroit 2Health News:California Nurses Association, Courage Campaign, Arianna Huffington Team up for 'Yacht Party 2' TV Ad 2Health News:California Nurses Association, Courage Campaign, Arianna Huffington Team up for 'Yacht Party 2' TV Ad 3Health News:FLDS Couple Seeks Emergency Order to Stop Infant Seizure, Say Perry & Haas 2Health News:FLDS Couple Seeks Emergency Order to Stop Infant Seizure, Say Perry & Haas 3Health News:Actifirm Sells Out in First Hour Appearance on QVC 2
... the challenge of,controlling costs while handling ... data,management is critical. INFINITY modular,patient monitors ... clinical information,wherever you are in the ... your job easier. You can monitor,your ...
... The biograph 6 offers ... improved disease diagnosis and treatment ... It delivers high-quality PET/CT whole ... 15 minutes. Our comprehensive suite ...
... offers the ultimate PET/CT performance ... treatment in oncology, neurology, and ... whole body scans in less ... suite of clinical applications offers ...
... Duo is a SmartBeam platform providing high-performance ... of the two most clinical sites - ... at a low radiation dose., ,The ... Windows, optimizes productivity and ensures consistant results. ...
Medicine Products: